After attending this webinar, participants will be able to:

• Describe how mouse models can be used to investigate disease phenotypes that are difficult to assess directly in humans.
• Describe the major proteomic changes associated with NPM1-mutant AML and how these can be leveraged to design treatment strategies.
• Recognize how integrating multiple omics datasets (e.g., RNA-seq and proteomics) from the same model can reveal interesting transcriptional regulation patterns.
• Explain the workflow from omics data generation to the identification and validation of potential therapeutic vulnerabilities.

• Research trainees interested in learning new hematology research methods
• Acute Myeloid Leukemia researchers of all career levels
• Medical students and those building core hematology knowledge
• Residents and practitioners in primary care requiring hematology fundamentals